LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and AI solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13-14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event will gather students, faculty, and professionals from systems engineering and healthcare disciplines, including pharmacy, dentistry, and laboratory sciences, to explore practical applications of AI and automation.
Representing LataMed AI will be CEO Dr. Kevin Rodan Levy and CFO Carlos Pena. Their presentation will address the evolving role of AI in healthcare, systems engineering, digital infrastructure, and professional decision-making. The company plans to discuss how AI-supported tools can assist healthcare professionals with medical-data evaluation, clinical workflows, and operational decision-making, as well as how automation can enhance the organization, reliability, and efficiency of technology systems in healthcare and other complex environments.
A key focus of the presentation will be the importance of maintaining qualified professional oversight when implementing AI. LataMed AI emphasizes that its technologies are designed to augment human capabilities and support informed decision-making, not replace the judgment of healthcare professionals, engineers, or laboratory personnel. Additional topics will include integration of AI into existing systems, responsible data use, privacy and information security, operational risk management, and practical considerations for developing and deploying technology in healthcare settings.
The company also intends to discuss the ongoing development of its healthcare technology ecosystem, highlighting CardioAI, PulmoAI, and NeuroAI—AI-supported platforms designed to assist professionals in evaluating cardiovascular, pulmonary, and neurological health information, subject to continued development and regulatory approval.
Dr. Kevin Rodan Levy commented, "Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of AI in healthcare and systems engineering. Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the development of healthcare infrastructure in Latin America."
Management believes that engagement with universities can increase awareness of emerging healthcare technologies and foster responsible discussion about AI, while strengthening relationships with future professionals. Participation also offers insights into student and educator perspectives as the company develops digital health and AI solutions for the region. This involvement aligns with LataMed AI's broader strategy of supporting education and responsible adoption of digital healthcare infrastructure.
Importantly, participation in the conference does not constitute endorsement by Universidad Santa Maria, nor does it guarantee future collaborations or financial benefits. For more information, visit https://latamed.ai or review filings with the SEC at www.sec.gov.
